1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, October 2016 (p20)

Biopharmaceutical Analysis & Statistics, October 2016 (p20)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

571-600 of about 1400 reports

Purchase Reports From Reputable Market Research Publishers

Tangential Flow Filtration Market Product (Cassettes, Cartridges), Membrane Material (Polyethersulfone, Regenerated Cellulose), Technology (Ultrafiltration, Microfiltration), Pore Size (Ultrafilters), Application (Bioprocess) Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The tangential flow filtration market is projected to reach USD 1,005.0 million by 2021 USD 554.7 million in 2016, growing at a CAGR of 12.6% during the forecast period (2016–2021). Growth in the bi ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : North America, World

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • Industry report
  • October 2016
  • by Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The ...

  • Industries : Biopharmaceutical, Generic Drug, Biotechnology, Pharmaceutical
  • Countries : World

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

  • Industries : Biopharmaceutical, Generic Drug, Pharmaceutical
  • Countries : World, Asia, Europe, North America

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • $ 1200
  • Industry report
  • October 2016
  • by PNS Pharma

“Remicade (Infliximab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 17 biosimilar version of Remicade drug in clinical pipeline. Currently there are ...

  • Industries : Therapy, Biopharmaceutical, Oncology

Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight

  • $ 1000
  • Industry report
  • October 2016
  • by PNS Pharma

“Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Lantus drug in clinical pipeline. Currently ...

  • Industries : Biopharmaceutical, Therapy

Humira Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States

Enbrel Biosimilars Clinical Trial Insight

  • $ 1500
  • Company report
  • October 2016
  • by PNS Pharma

“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars ...

  • Industries : Biopharmaceutical

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • $ 1500
  • Company report
  • October 2016
  • by PNS Pharma

“Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Herceptin drug in clinical pipeline. Currently there ...

  • Industries : Therapy, Biopharmaceutical, Oncology

LG Life Science LTD. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • September 2016
  • by Global Markets Direct

LG Life Science LTD. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘LG Life Science LTD. - Product Pipeline Review - 2016’, provides an overview of the LG Life Science LTD.’s ...

  • Industries : Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : World

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C ...

  • Industries : Biological Therapy, Pathology, Chronic Disease, Biotechnology
  • Countries : United States

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016 Summary ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology
  • Countries : World, United States, Japan, Israel

Hemophilia B - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hemophilia B - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology
  • Countries : United States, World, Europe

Hepatitis C - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hepatitis C - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Eukaryotic Translation Initiation ...

  • Industries : Cancer, Biopharmaceutical, Therapy, Pathology, Drug Discovery and Development
  • Countries : World, United States

Biocon Limited - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • September 2016
  • by Global Markets Direct

Biocon Limited - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Biocon Limited - Product Pipeline Review - 2016’, provides an overview of the Biocon Limited’s pharmaceutical research ...

  • Industries : Therapy
  • Countries : World, India

Connexin (Gap Junction Protein) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Connexin (Gap Junction Protein) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Connexin (Gap Junction Protein) - Pipeline Review, H2 2016’, provides in depth analysis on Connexin (Gap ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : France, World

Liver Transplant Rejection Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Liver Transplant Rejection Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Blood Supply, Tissue Banking and Transplantation, Pharmaceutical, Healthcare, Therapy
  • Countries : World

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Chronic Disease, Healthcare
  • Countries : World

Lung Transplant Rejection Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Lung Transplant Rejection Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Lung Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World

Kaposi Sarcoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Kaposi Sarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Kaposi Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Kaposi Sarcoma clinical ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World

Heart Transplant Rejection Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Heart Transplant Rejection Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Pharmaceutical, Drug Discovery and Development
  • Countries : World

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : Europe, United States, World

Analysis of the Western European Protein Ingredients Market

  • $ 3000
  • Industry report
  • September 2016
  • by Frost & Sullivan

Increasing Consumer Health Consciousness to Propel Growth in the European Proteins Market The Western European protein ingredients market was $10.89 billion in 2015 and is likely to expand at an attractive ...

  • Industries : Biopharmaceutical
  • Countries : Europe

Neutropenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H2 2016’, provides an overview of the Neutropenia pipeline landscape. The report provides comprehensive ...

  • Industries : Pharmaceutical, Biopharmaceutical, Biological Therapy, Biotechnology, Therapy
  • Countries : United States

Myocardial Infarction - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Myocardial Infarction - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2016’, provides an overview of the Myocardial Infarction pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States

Hypersensitivity - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hypersensitivity - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape. The report ...

  • Industries : Pharmaceutical, Therapy, Pathology, OTC
  • Countries : United States, World, Japan

Psoriasis - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • September 2016
  • by Global Markets Direct

Psoriasis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Fibrosis ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.